Founded
Address
Vivo Ventures LLC
575 High Street
Suite 201
Palo Alto, CA 94301
United States
Phone
Website
Recent investment activity
KANDO id: 30821
Corporate information
Registration country
Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Vivo Ventures Fund VII LP | Venture | USD | 350,000,000 | |
| Vivo Ventures VII Affiliates Fund LP | Venture |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 49| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Abraxis Bioscience Inc | A strategically integrated pharmaceutical company that manufactures, markets and develops injectable products | N/A | |||
|
|
Allos Therapeutics Inc | N/A | ||||
|
|
Alpha Innotech Corp | Genomic tools company providing signal detection, digital imaging and application support to the life science markets. | N/A | |||
|
|
AMAG Pharmaceuticals Inc | N/A | ||||
|
|
Angiogenix Inc | Biotechnology company developing products for peripheral and cardiac ischemia. | N/A | |||
|
|
Aspreva Pharmaceuticals Ltd | N/A | ||||
|
|
Avanir Pharmaceuticals Inc | A biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. | N/A | |||
|
|
Biodel Inc | A biopharmaceutical company focused on the development and commercialization of treatments for diabetes | Series B | |||
|
|
BioForm Medical Inc | Is a medical aesthetics company dedicated to bringing doctors and their patients safe and effective products. | N/A | |||
|
|
CAPNIA Inc | Series C | ||||
|
|
Carbylan BioSurgery Inc | Series B | ||||
|
|
Chelsea Therapeutics | A development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of diseases. | N/A | |||
|
|
Copernicus Therapeutics Inc | Developer of a non-viral delivery system for the non-toxic delivery of nucleic acid drugs. | N/A | |||
|
|
CoTherix Inc | N/A | ||||
|
|
Dynavax Technologies Corp | N/A | ||||
|
|
Eiger BioPharmaceuticals | A biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. | Series A | |||
|
|
Essentialis Inc | Developing a novel therapy for the treatment of dyslipidemia. | Series B | |||
|
|
Hamilton Pharmaceuticals Inc | Developing novel treatments for central nervous system disease. | N/A | |||
|
|
InterMune Inc | Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. | N/A | |||
|
|
Nora Therapeutics Inc | Specialty biopharmaceutical company that focuses on developing therapeutics to address clinical unmet needs in reproductive medicine. | N/A | |||
|
|
OncoGenex Pharmaceuticals | A biopharmaceutical company committed to the development and commercialization of new cancer therapies. | N/A | |||
|
|
Palatin Technologies Inc | Develops peptide, peptide mimetic and small molecule agonists with a focus on melanocortin and natriuretic peptide receptor systems | N/A | |||
|
|
Pepgen Corp | Biopharmaceutical company engaged in the development of novel autoimmune, inflammatory, and viral therapies. | N/A | |||
|
|
Prestwick Pharmaceuticals Inc | A specialty pharmaceutical company engaged in the development and marketing of drugs for diseases of the CNS. | N/A | |||
|
|
Revance Therapeutics Inc | Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. | Venture |
Team
| Employee | Position | |||
|---|---|---|---|---|
| Albert Cha | [email protected] | |||
| Edgar G Engleman | [email protected] | |||
| Frank Kung | [email protected] | |||
| Edgar Engleman | ||||
| Mahendra G Shah | ||||
| Chen Yu | ||||
| James Zhao | ||||
| Hao Zhou |
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
| James Huang | KPCB China |